Stocks Health care ALURD
OTC · Health careAllurion Technologies, Inc. (ALURD)
Allurion Technologies, Inc. brought in $12.6M of revenue over the twelve months to March 31, 2026, down 55.5% from a year earlier. It posted a net loss of $33.3M. At March 31, 2026 it held $5.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on May 15, 2026.
Key facts about Allurion Technologies, Inc.
- Net worth
- Allurion Technologies, Inc. has a market value (market cap) of $26.3M at the latest share price, and shareholders' equity of -$77.9M on its balance sheet at March 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $15.2M (-52.6% year on year), with a net loss of $28.8M. Over the 12 months to March 31, 2026: revenue $12.6M, net loss $33.3M.
- Cash flow
- In fiscal 2025 operations used $28.9M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on May 15, 2026 and covers the period to March 31, 2026. Open on SEC EDGAR
What Allurion Technologies, Inc. does
Allurion Technologies, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker ALURD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $15.2M | -$28.8M | -$3.81 | n/a |
| 2024 | $32.1M | -$7.2M | -$3.20 | -$42.9M |
| 2023 | $53.5M | -$82.8M | -$59.38 | -$65.6M |
| 2023 | $64.2M | -$37.7M | -$37.75 | -$48.5M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where ALURD ranks in Health care
Latest SEC filings
What Allurion Technologies, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 2, 2026Activist stake changed SCHEDULE 13D/A
- August 24, 2026
- August 14, 2026Late quarterly report notice NT 10-Q
- July 24, 2026
- July 23, 2026Activist stake changed SCHEDULE 13D/A
- July 23, 2026
- July 7, 2026
- June 30, 2026
- June 17, 2026
- May 27, 2026Auditor change 8-K
Insider trades
What the people running Allurion Technologies, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| July 21, 2026 | Rtw Investments, LP10% owner | Other changeindirect | 209,254 | - |
| July 21, 2026 | Rtw Investments, LP10% owner | Other changeindirect | 161,807 | - |
| July 21, 2026 | Rtw Investments, LP10% owner | Other changeindirect | 19,934 | - |
| July 21, 2026 | Rtw Investments, LP10% owner | Other changeindirect | 1,771 | - |
| December 4, 2025 | Davin Michael RDirector | Soldindirect | 1,606 | $2.5K |
| December 3, 2025 | Davin Michael RDirector | Soldindirect | 1,606 | $2.4K |
| November 26, 2025 | Davin Michael RDirector | Gave as a gift | 2,608 | - |
| November 26, 2025 | Davin Michael RDirector | Gave as a giftindirect | 2,608 | - |
Who owns ALURD
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| RTW Investments, LP13D, may seek influence with 1 related filers | 9.9% | September 2, 2026 |
| Leavitt Equity Partners III, L.P.13G, passive with 4 related filers | 7.8% | February 26, 2025 |
Largest institutional holders
Insiders
1 insiders reported holding 1,206 shares in total, about $2.1K at the last price.
| Holder | Shares |
|---|---|
| Davin Michael RDirector | 1,206 |
Questions about ALURD
What does Allurion Technologies, Inc. do?
Allurion Technologies, Inc. is a company in the Health care sector, listed on OTC as ALURD. Its shares trade on OTC under the ticker ALURD.
What is Allurion Technologies, Inc.'s net worth?
Allurion Technologies, Inc. has a market value (market cap) of $26.3M at the latest share price, and shareholders' equity of -$77.9M on its balance sheet at March 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Allurion Technologies, Inc. profitable?
No. Over the twelve months to March 31, 2026 it reported a net loss of $33.3M on revenue of $12.6M.
How much revenue does Allurion Technologies, Inc. make?
Over the twelve months to March 31, 2026 Allurion Technologies, Inc. reported revenue of $12.6M. That is 55.5% less than a year earlier.
When did Allurion Technologies, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on May 15, 2026. It covers the period to March 31, 2026. Its newest filing of any kind is the activist stake changed from September 2, 2026.
Similar companies
Compare ALURD with
Compare ALURD with any company
Follow ALURD
Get an email when Allurion Technologies, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Allurion Technologies, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.